{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "30305295",
  "DateCompleted": {
    "Year": "2019",
    "Month": "02",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "05",
    "Day": "03"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2018",
        "Month": "10",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1136/bmj.k3786"
    ],
    "Journal": {
      "ISSN": "1756-1833",
      "JournalIssue": {
        "Volume": "363",
        "PubDate": {
          "Year": "2018",
          "Month": "Oct",
          "Day": "10"
        }
      },
      "Title": "BMJ (Clinical research ed.)",
      "ISOAbbreviation": "BMJ"
    },
    "ArticleTitle": "What treatments are effective for common cold in adults and children?",
    "Pagination": {
      "StartPage": "k3786",
      "MedlinePgn": "k3786"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, University of Queensland, Brisbane, Australia m.vandriel@uq.edu.au."
          }
        ],
        "LastName": "van Driel",
        "ForeName": "Mieke L",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium."
          }
        ],
        "LastName": "Scheire",
        "ForeName": "Sophie",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Faculty of Medicine, University of Queensland, Brisbane, Australia."
          }
        ],
        "LastName": "Deckx",
        "ForeName": "Laura",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Ear, Nose and Throat, Ghent University, Ghent, Belgium."
          }
        ],
        "LastName": "Gevaert",
        "ForeName": "Philippe",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Family Medicine and Primary Health Care, Ghent University, Ghent, Belgium."
          }
        ],
        "LastName": "De Sutter",
        "ForeName": "An",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "BMJ",
    "NlmUniqueID": "8900488",
    "ISSNLinking": "0959-8138"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nasal Decongestants"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nonprescription Drugs"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Histamine Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Nasal Decongestants"
    },
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Nonprescription Drugs"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Guidelines as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Patterns, Physicians'"
    }
  ],
  "CoiStatement": "Competing interests: We have read and understood the BMJ policy on declaration of interests and declare no relevant financial interests. Mieke van Driel declares payment from IN VIVO Academy Ltd to develop materials for an educational programme on Medication Overuse Headache supported by a competitive unrestricted grant from Pfizer. Philippe Gevaert declared advisory board membership and paid consultancy with Sanofi which produces Dupilumab and Roche which produces Xolair, both for Chronic Rhinosinusitis with nasal polyps."
}